Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04765592 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 30, 2024 (before its estimated February 5, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Notable Primary completion date: Feb 15, 2023 to Feb 5, 2025v3 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 80 to confirmed 88
    • Study completion date: Aug 1, 2024 to Feb 5, 2029
    • Site details revised at 23 of 23 sites
  2. Notable Primary completion date: Feb 15, 2022 to Feb 15, 2023
    • Study completion date: Jan 1, 2023 to Aug 1, 2024
    • Start date changed from estimate of Apr 25, 2021 to Jun 7, 2021
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System manufactured by EndoNom Medtech (Hangzhou) Co., Ltd. for true/false aortic arch aneurysms and ulcers involving aortic arch . (GIANT Study)
Trial Details
NCT Number NCT04765592
Lead Sponsor Hangzhou Endonom Medtech Co., Ltd.
Conditions
(from sponsor)
Aortic Arch Aneurysm
Related terms Aneurysm, Aortic Arch
Enrollment 88 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov